Fisher Asset Management LLC Has $60.92 Million Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)

Fisher Asset Management LLC increased its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 47.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 183,353 shares of the company's stock after purchasing an additional 58,954 shares during the period. Fisher Asset Management LLC owned 0.59% of Medpace worth $60,916,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. R Squared Ltd acquired a new stake in shares of Medpace in the 4th quarter worth $30,000. Stone House Investment Management LLC purchased a new stake in Medpace in the third quarter valued at approximately $33,000. Ashton Thomas Securities LLC acquired a new position in Medpace during the third quarter worth approximately $37,000. Capital Performance Advisors LLP acquired a new position in Medpace during the third quarter worth approximately $46,000. Finally, True Wealth Design LLC grew its stake in Medpace by 16,800.0% during the third quarter. True Wealth Design LLC now owns 169 shares of the company's stock worth $56,000 after buying an additional 168 shares during the period. Institutional investors and hedge funds own 77.98% of the company's stock.

Analysts Set New Price Targets

Separately, Robert W. Baird upped their target price on shares of Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, Medpace has a consensus rating of "Hold" and an average target price of $381.44.

Remove Ads

Medpace Stock Up 1.3 %

Shares of NASDAQ:MEDP traded up $4.17 during trading on Wednesday, reaching $328.56. The stock had a trading volume of 272,807 shares, compared to its average volume of 300,169. The stock has a fifty day simple moving average of $341.61 and a two-hundred day simple moving average of $344.15. The firm has a market capitalization of $10.01 billion, a price-to-earnings ratio of 26.01, a P/E/G ratio of 3.81 and a beta of 1.36. Medpace Holdings, Inc. has a 52 week low of $302.01 and a 52 week high of $459.77.

Medpace (NASDAQ:MEDP - Get Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, topping analysts' consensus estimates of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. On average, analysts forecast that Medpace Holdings, Inc. will post 12.29 EPS for the current year.

Medpace Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.